Goldman Sachs Group Inc Vor Biopharma Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Vor Biopharma Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 180,788 shares of VOR stock, worth $5.36 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
180,788
Previous 84,945
112.83%
Holding current value
$5.36 Million
Previous $61,000
378.69%
% of portfolio
0.0%
Previous 0.0%
Shares
19 transactions
Others Institutions Holding VOR
# of Institutions
43Shares Held
55.7MCall Options Held
4.15MPut Options Held
364K-
Ra Capital Management, L.P. Boston, MA39.6MShares$1.18 Billion1.4% of portfolio
-
5 Am Venture Management, LLC San Francisco, CA6.36MShares$189 Million6.91% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.92MShares$56.8 Million0.0% of portfolio
-
Ubs Group Ag1.53MShares$45.4 Million0.0% of portfolio
-
Johnson & Johnson New Brunswick, NJ1.07MShares$31.9 Million0.59% of portfolio
About Vor Biopharma Inc.
- Ticker VOR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 38,056,300
- Market Cap $1.13B
- Description
- Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AM...